Korro Bio Inc. (KRRO) Company Profile & Statistics

Korro Bio Inc.
KRRO
(Nasdaq - US)
Closed
46.62
-0.94 (-1.98%)
in:usd•As of: Nov 18, 2024 15:59 UTC -5
Open
47.74
High
51.37
Low
46.62

About Korro Bio Inc.

CEO

Ram Aiyar

Headquarters

one kendall square. building 600-700,suite 6-401

cambridge, ma 02139, united states

Auditor

Ernst & Young LLP

Employees

101

Share Holders

Website

www.korrobio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.

Korro Bio Inc. Statistics

Valuation Measures

Market Capitalization ²	436.83M
Enterprise Value	373.62M
Enterprise Value/EBITDA (ttm)	-3.99
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.46
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-50.25%
Return on Invested Capital (ttm)	-50.59%
Return on Assets (ttm)	-38.48%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-93.62M
Net Income Avi to Common (ttm)	-87.81M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	2.05
52-Week Change	23.79%
S&P500 52-Week Change	29.60%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	9.37M
Dividend Yield	0.00%
Float ⁴	8.86M
% Held by Insiders	5.40%
% Held by Institutions	13.18%

Balance Sheet

Total Cash (mrq)	137.00M
Total Cash Per Share (mrq)	14.62
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	11.23%
Quick Ratio (mrq)	11.23%
Book Value Per Share (mrq)	19.28

Cash Flow

Operating Cash Flow Per Share (ytd)	-5.65
Free Cash Flow (ytd)	-69.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Korro Bio Inc.

Trade With A Regulated Broker